Skip to main content
Wednesday, November 11, 2026Nov 11

Forget EpiPens. This San Diego biotech is offering the same medicine without needles

Richard Lowenthal is the President and Chief Executive Officer of ARS Pharmaceuticals, holds a case for its product Neffy in San Diego. ARS Pharmaceuticals received FDA approval for Neffy, a nasal spray alternative to the EpiPen. (K.C. Alfred/The San Diego Union-Tribune/TNS)
Richard Lowenthal is the President and Chief Executive Officer of ARS Pharmaceuticals, holds a case for its product Neffy in San Diego. ARS Pharmaceuticals received FDA approval for Neffy, a nasal spray alternative to the EpiPen. (K.C. Alfred/The San Diego Union-Tribune/TNS) Richard Lowenthal is the President and Chief Executive Officer of ARS Pharmaceuticals, holds a case for its product Neffy in San Diego. ARS Pharmaceuticals received FDA approval for Neffy, a nasal spray alternative to the EpiPen. (K.C. Alfred/The San Diego Union-Tribune/TNS)

Alyssa Bauder was just learning how to read, but she had already memorized the colors of food packaging that spelled danger for her: peanuts. The 6-year-old knew to stay away from chocolate dressed in orange or blue and yellow wrappers.

Then everything got bungled on Valentine’s Day. Her first grade class exchanged handfuls of candy all disguised in special pink and red designs.

When Alyssa got home, she tore away the pretty candy wrapper and took a bite of a mini chocolate bar not knowing it was a Butterfinger. Immediately, something didn’t feel right.

Was it her chest or her throat that felt funny?

She wanted water, but couldn’t move.